Roivant Sciences Reports Q4 2025 Earnings Miss but Shows Strong Revenue GrowthRoivant Sciences reported a 87% revenue increase in Q4 2025, but missed earnings expectations, with a GAAP EPS of -$0.29 and revenue of $7.57 million.Roivant Sciences Ltd Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 2025-05-29 2 minutes to read
Roivant Sciences Awaits Earnings Report Amid Revenue Growth and Loss ProjectionsRoivant Sciences Ltd is set to release its Q4 2025 earnings on May 29, 2025, with analysts expecting a mixed bag of results, including a revenue surge but a loss per share.Roivant Sciences Ltd Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 2025-05-29 2 minutes to read